DAFALGAN 1000 mg, film-coated tablet 8 tablets, CIP 3400930170441
Brand page: Doliprane, Dafalgan, Efferalgan (paracetamol) — all forms and strengths in France
Active ingredients: Paracetamol
Commercialized according to BDPM
Film-coated tablet8 tablets, CIP 3400930170441orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DAFALGAN 1000 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- tube(s) polypropylène de 8 comprimé(s)
- Marketing authorisation holder
- UPSA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 Jan 2021
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62887947CIP73017044CIP133400930170441Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PARACÉTAMOLcomprimé | 1 g · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.